Main Content start here
Main Layout
Report Description

Report Description

Key Insights

Details

Forecast Period

2027-2031

Market Size (2025)

USD 619.33 Million

CAGR (2026-2031)

12.88%

Fastest Growing Segment

Polymer

Largest Market

West

Market Size (2031)

USD 1281.22 Million

Market Overview

The India Microfluidics Market is expected to grow from USD 619.33 Million in 2025 to USD 1281.22 Million by 2031 at a 12.88% CAGR. Microfluidics involves the precise manipulation of minute fluid volumes, typically from microliters to picoliters, within microscale channels and chambers for diagnostic, pharmaceutical, and research applications. The India Microfluidics Market growth is primarily supported by the escalating demand for point-of-care diagnostics, the rising prevalence of chronic diseases, and continuous technological advancements enabling lab-on-chip solutions. According to the India Brand Equity Foundation (IBEF), citing the India Bioeconomy Report, in 2025, India's bioeconomy, a sector significantly impacted by microfluidics, reached US$ 195.30 billion.

A significant challenge impeding market expansion includes the high initial manufacturing costs associated with microfluidic device production. This is coupled with the complexities involved in integrating these advanced technologies into existing healthcare and research workflows, in addition to the limited standardization across various microfluidic platforms.

Key Market Drivers

Rising disease burden drives microfluidic diagnostics adoption
The increasing prevalence of chronic and infectious diseases significantly drives the India Microfluidics Market, creating an urgent need for advanced diagnostic tools. Microfluidic devices offer advantages such as faster turnaround times, higher sensitivity, and lower sample volumes, crucial for managing widespread health conditions. The substantial burden of non-communicable diseases (NCDs) like diabetes and cardiovascular diseases, alongside persistent infectious diseases, necessitates efficient and accessible diagnostic solutions for early detection and monitoring. According to the World Health Organization (WHO), in April 2026, a report highlighted that NCDs account for approximately 63% of all deaths in India. This high prevalence drives the adoption of microfluidic platforms for comprehensive disease management.

POCT growth and government support spur microfluidics expansion
The growing demand for point-of-care testing (POCT) significantly propels the India Microfluidics Market, inherently suitable for decentralized diagnostics. Microfluidic devices enable portable, user-friendly systems delivering rapid results outside conventional laboratory settings, addressing critical needs in remote areas and primary healthcare centers. This capability enhances accessibility and expedites treatment, particularly for infectious disease outbreaks and chronic disease monitoring across India. According to Sanstrat, in March 2025, the Indian Point-of-Care (POC) testing market was experiencing significant growth, projected to reach approximately US$ 1 billion by 2027. Furthermore, initiatives promoting local manufacturing under 'Make in India' support microfluidics growth by fostering domestic production of these advanced diagnostic devices. According to the Department of Biotechnology (DBT), in February 2025, the DBT was allocated ₹3,446 crore, reflecting a 50% increase from the previous year, which supports biotechnology research and development relevant to microfluidics.

Download Free Sample Report

Key Market Challenges

Upfront Capital Costs Limit Market Expansion and R&D
High initial manufacturing costs represent a significant barrier to the expansion of the India Microfluidics Market. The specialized materials, precision fabrication techniques, and stringent quality controls necessary for producing microfluidic devices demand substantial upfront capital expenditure. This financial requirement often restricts the ability of domestic manufacturers, particularly smaller enterprises, to invest sufficiently in essential infrastructure and advanced research and development for innovative microfluidic solutions.

Elevated Costs Raise Unit Prices, Hindering Adoption
The elevated production expenses directly contribute to higher unit costs for microfluidic products. This impacts their widespread adoption within a price-sensitive market like India, where affordability is a key factor for market penetration across diverse healthcare and research settings. According to the Association of Indian Medical Device Industry (AIMED), in 2026, domestic manufacturers encounter a 10–15% cost disadvantage, largely attributed to high capital and energy costs, coupled with inadequate testing and research infrastructure. This cost disparity directly hampers the competitiveness of domestically produced microfluidic devices against more affordably priced imported alternatives, thereby limiting overall market growth.

Key Market Trends

AI-Driven Microfluidic Diagnostics and Investment Momentum
The integration of Artificial Intelligence in microfluidic diagnostics represents a significant transformative trend within the India Microfluidics Market. This involves leveraging AI for enhanced data analysis, automation of complex diagnostic processes, and improved accuracy in disease detection, particularly in resource-constrained settings. AI-driven microfluidic solutions can interpret intricate biological data rapidly, reducing human error and offering quicker diagnostic insights. This trend is further propelled by substantial investment in the broader health technology sector. According to Digital Health News, in July 2026, total funding for HealthTech startups in India reached $707 million in the first half of 2026, demonstrating strong investor confidence in technology-driven healthcare solutions, including those integrating AI into diagnostics.

Frugal, Scalable Microfluidics and Domestic Manufacturing Initiatives
Another pivotal trend is the increasing focus on frugal and scalable microfluidic diagnostic solutions. Given India's diverse healthcare landscape and emphasis on affordability, there is a strong drive towards developing cost-effective, easily deployable microfluidic devices that can cater to both urban and rural populations. This trend addresses the high initial manufacturing costs often associated with advanced medical technologies by promoting indigenous design and production, ensuring broader accessibility. This is supported by government initiatives aimed at bolstering domestic manufacturing. According to the India Brand Equity Foundation, in September 2026, the Centre invited proposals under a Rs. 500 crore (US$ 53.96 million) scheme, launched in November 2024 by the Department of Pharmaceuticals, designed to boost domestic medical device manufacturing and reduce import dependence.

Segmental Insights

Polymer Advantage Accelerates Growth in India's Microfluidics for Affordable POC Diagnostics Under Ayushman Bharat
The Polymer segment is a key driver of growth in the India Microfluidics Market, demonstrating the fastest expansion due to several compelling advantages. The inherent cost-effectiveness and ease of fabrication associated with polymer materials, notably polydimethylsiloxane, make them highly suitable for developing affordable and high-volume diagnostic solutions, a critical requirement in India's cost-sensitive healthcare landscape. This facilitates the widespread adoption of point-of-care testing devices, aligning with government initiatives like Ayushman Bharat to expand accessible healthcare nationwide. Furthermore, polymers offer desirable properties such as biocompatibility and optical transparency, which are essential for diverse biomedical applications, while advancements in polymer fabrication techniques further support their rapid integration into new microfluidic systems.

Regional Insights

West India Leads Microfluidics Market Through Healthcare Infrastructure and Biotech Ecosystem
The West region is anticipated to lead India's Microfluidics Market, driven by its well-established healthcare infrastructure and substantial investment in biotechnology and pharmaceutical research. States such as Maharashtra and Gujarat, forming key biotech and pharma hubs, possess a robust ecosystem of research institutions, academic collaborations, and industry partnerships. This environment actively fosters innovation and advancements in microfluidics technology. The concentration of advanced medical facilities and a thriving life sciences sector within this region provides a strong foundation for the development and adoption of microfluidic devices for diverse applications, including diagnostics and drug discovery.

Recent Developments

  • In July 2025, Bengaluru-based medtech startup SigTuple was noted for its AI-powered diagnostic device, AI100, which integrates microfluidics into Indian pathology. This innovation automates the manual microscopic review of biological samples, aiming to significantly reduce diagnostic time and potential human error. The AI100 device combines artificial intelligence, robotics, microfluidics, and cloud computing to offer a comprehensive solution that improves efficiency and accuracy in pathology laboratories. This breakthrough is particularly impactful for the India Microfluidics Market by addressing the shortage of pathologists and enhancing diagnostic accessibility in underserved regions across the country.
  • In December 2024, Syensqo, a specialty chemicals company, announced a strategic partnership with Emulseo, a French firm specializing in microfluidic formulations. This collaboration aimed to advance droplet-based microfluidic technology for healthcare applications, relevant to the India Microfluidics Market. Emulseo planned to integrate Syensqo's Galden® PFPE, a fluorinated fluid known for its inertness and optical clarity, into its Fluo-Oil range. The objective of this partnership was to enhance diagnostic tools for areas such as cancer detection and accelerate vaccine development. This initiative highlights ongoing efforts to explore new opportunities within the expanding microfluidics sector.
  • In August 2024, SigTuple, an Indian medtech startup, confirmed its plans for two significant new product launches within the year, targeting a broad segment of the diagnostic industry. The company, which had recently secured INR 33 crore (USD 4 million) in an extended Series C funding round, intended to leverage this capital to expand its product portfolio and secure regulatory clearances. These upcoming product introductions, following the successful regulatory approval of its AI100 device, were anticipated to establish SigTuple as a prominent global brand originating from India, further strengthening its presence in the India Microfluidics Market with advanced diagnostic solutions.
  • In April 2024, IDEX's Microfluidics unit, a part of IDEX Material Processing Technology, was recognized with a Biotech Innovation Award for its new MP350 Microlyser™ processor. This advanced biopharma-grade processor was engineered for large-scale cell disruption, a crucial step in producing biological products like vaccine antigens and gene therapy viral vectors. The technology was a result of collaborative development efforts by IDEX MPT teams located in both India and the United States. This award underscores the processor’s ability to simplify and improve existing biopharmaceutical processes, signifying a notable contribution to the India Microfluidics Market's technological advancements.

Key Market Players

  • AQC Chem. Lab Pvt Ltd.
  • Bio-Rad Laboratories India Pvt Ltd
  • Abbott India Ltd
  • PerkinElmer India Pvt Ltd
  • Thermo Fisher Scientific India Pvt. Ltd.

By Product Type

By Material

By Application

By End User

By Region

  • Microfluidic Chips
  • Microfluidic Sensors
  • Microfluidic Pumps
  • Microneedles
  • Others
  • Polymer
  • Glass
  • Silicon
  • PDMS
  • Other
  • In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing)
  • Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction)
  • Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps)
  • Hospitals & Diagnostic Centres
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • North India
  • East India
  • West India
  • South India

Report Scope:

In this report, the India Microfluidics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • India Microfluidics Market, By Product Type:
  • Microfluidic Chips
  • Microfluidic Sensors
  • Microfluidic Pumps
  • Microneedles
  • Others
  • India Microfluidics Market, By Material:
  • Polymer
  • Glass
  • Silicon
  • PDMS
  • Other
  • India Microfluidics Market, By Application:
  • In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing)
  • Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction)
  • Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps)
  • India Microfluidics Market, By End User:
  • Hospitals & Diagnostic Centres
  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • India Microfluidics Market, By Region:
  • North India
  • East India
  • West India
  • South India

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the India Microfluidics Market.

Available Customizations:

India Microfluidics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

India Microfluidics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.  Markets Covered

1.2.2.  Years Considered for Study

1.2.3.  Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    India Microfluidics Market Outlook

5.1.  Market Size & Forecast

5.1.1.  By Value

5.2.  Market Share & Forecast

5.2.1.  By Product Type (Microfluidic Chips, Microfluidic Sensors, Microfluidic Pumps, Microneedles, Others)

5.2.2.  By Material (Polymer, Glass, Silicon, PDMS, Other)

5.2.3.  By Application (In Vitro diagnostics (Point-of-Care Testing, Clinical Diagnostics, Environmental Testing, Industrial Testing, Agro Food Testing), Pharmaceutical Research (Lab Analytics, Microdispensing, Microreaction), Drug Delivery (Inhaler Nozzles, Microneedles, Micropumps))

5.2.4.  By End User (Hospitals & Diagnostic Centres, Academic & Research Institutes, Pharmaceutical & Biotechnology Companies)

5.2.5.  By Region

5.2.6.  By Company (2025)

5.3.  Market Map

6.    North Microfluidics Market Outlook

6.1.  Market Size & Forecast

6.1.1.  By Value

6.2.  Market Share & Forecast

6.2.1.  By Product Type

6.2.2.  By Material

6.2.3.  By Application

6.2.4.  By End User

7.    East Microfluidics Market Outlook

7.1.  Market Size & Forecast

7.1.1.  By Value

7.2.  Market Share & Forecast

7.2.1.  By Product Type

7.2.2.  By Material

7.2.3.  By Application

7.2.4.  By End User

8.    West Microfluidics Market Outlook

8.1.  Market Size & Forecast

8.1.1.  By Value

8.2.  Market Share & Forecast

8.2.1.  By Product Type

8.2.2.  By Material

8.2.3.  By Application

8.2.4.  By End User

9.    South Microfluidics Market Outlook

9.1.  Market Size & Forecast

9.1.1.  By Value

9.2.  Market Share & Forecast

9.2.1.  By Product Type

9.2.2.  By Material

9.2.3.  By Application

9.2.4.  By End User

10.    Market Dynamics

10.1.  Drivers

10.2.  Challenges

11.    Market Trends & Developments

11.1.  Merger & Acquisition (If Any)

11.2.  Product Launches (If Any)

11.3.  Recent Developments

12.    Competitive Landscape

12.1.  AQC Chem. Lab Pvt Ltd.

12.1.1.  Business Overview

12.1.2.  Products & Services

12.1.3.  Recent Developments

12.1.4.  Key Personnel

12.1.5.  SWOT Analysis

12.2.  Bio-Rad Laboratories India Pvt Ltd

12.3.  Abbott India Ltd

12.4.  PerkinElmer India Pvt Ltd

12.5.  Thermo Fisher Scientific India Pvt. Ltd.

13.    Strategic Recommendations

14.    About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the India Microfluidics Market was estimated to be USD 619.33 Million in 2025.

West is the dominating region in the India Microfluidics Market.

Polymer segment is the fastest growing segment in the India Microfluidics Market.

The India Microfluidics Market is expected to grow at 12.88% between 2026 to 2031.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.